Evidence map›Paper›PMID 41840226›Full record

ReviewLeukemia2026

Chronic myeloid leukaemia: have basophils gone the way of the Dodo bird?

Lucia Turcsanyi, Xiao-Shuai Zhang, Milos Kudelka, Kristyna Kubikova, Martin Radvansky, Sen Yang, Eva Kriegova, Jarmila Juranova, Jiri Mayer, Hana Klamova and 8 more

Abstract readReview
In one paragraph

Review in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Lucia TurcsanyiDepartment of Hemato-Oncology, Olomouc University Hospital and Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.
Xiao-Shuai ZhangPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China.ORCID http://orcid.org/0000-0001-5405-0802
Milos KudelkaDepartment of Computer Science, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, Ostrava, Czech Republic.
Kristyna KubikovaDepartment of Computer Science, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, Ostrava, Czech Republic.
Martin RadvanskyDepartment of Computer Science, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, Ostrava, Czech Republic.ORCID http://orcid.org/0000-0002-8421-7658
Sen YangPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China.
Eva KriegovaDepartment of Immunology, Olomouc University Hospital and Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.
Jarmila JuranovaDepartment of Hemato-Oncology, Olomouc University Hospital and Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.
Jiri MayerDepartment of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic.ORCID http://orcid.org/0000-0003-0567-9887
Hana KlamovaInstitute of Hematology and Blood Transfusion, Prague, Czech Republic.ORCID http://orcid.org/0009-0000-5020-7040
Petra Belohlavkova4th Department of Internal Medicine and Hematology, University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic.
Michal KarasDepartment of Hemato-oncology, University Hospital Pilsen and Charles University, Pilsen, Czech Republic.
Lukas StejskalDepartment of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
Eduard Cmunt1st. Internal Department, General University Hospital Prague, Prague, Czech Republic.
Megan OthusFred Hutchinson Cancer Research Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-8176-6371
Robert Peter GalePeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China.ORCID http://orcid.org/0000-0002-9156-1676
Qian JiangPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China. jiangqian@medmail.com.cn.ORCID http://orcid.org/0000-0001-7131-0522
Edgar FaberDepartment of Hemato-Oncology, Olomouc University Hospital and Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic. edgar.faber@fnol.cz.ORCID http://orcid.org/0000-0002-3259-7791

Funding

Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic) MH CZ - DRO (FNOL, 00098892)Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic) MH CZ-DRO (FNOL 00098892)Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic) MH CZ (FNOL, 00098892)Univerzita Palackého v Olomouci (Palacký University Olomouc) IGA_LF_2025_014Univerzita Palackého v Olomouci (Palacký University Olomouc) IGA_LF_2025_05Univerzita Palackého v Olomouci (Palacký University Olomouc) IGA_LF_2025_14
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41840226
PMCPMC13056533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.